BD, Gen-Probe Settle Patent Dispute | GenomeWeb

NEW YORK (GenomeWeb News) – Becton Dickinson said today that it and Hologic's Gen-Probe business have settled a patent dispute, and the company has been granted a license from Gen-Probe to make, use, and sell certain products that BD had been accused of infringing.

BD will make payments to Gen-Probe as part of the settlement, including upfront fees and ongoing royalties. BD did not specify the amounts of the payments but said they are not material to the firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.